# FDA Inspection 1008766 - Granite City Illinois Hospital Corporation, LLC - January 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/granite-city-illinois-hospital-corporation-llc/152c29ac-7df8-4161-b8b4-b1e74b33e2e4
Source feed: FDA_Inspections

> FDA Inspection 1008766 for Granite City Illinois Hospital Corporation, LLC on January 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008766
- Company Name: Granite City Illinois Hospital Corporation, LLC
- Inspection Date: 2017-01-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 894998 - 2014-09-17](https://www.keypedia.com/records/fda_inspections/granite-city-illinois-hospital-corporation-llc/b16c0f96-bcf7-49d7-9cd3-c5b406778509)
- [FDA Inspection 759282 - 2011-12-15](https://www.keypedia.com/records/fda_inspections/granite-city-illinois-hospital-corporation-llc/6470f7da-63b7-4981-b57d-30c1cb1393c6)
- [FDA Inspection 663949 - 2010-05-27](https://www.keypedia.com/records/fda_inspections/granite-city-illinois-hospital-corporation-llc/63f77c44-c5ff-4370-bc15-22484d4c0da2)

Company: https://www.keypedia.com/companies/granite-city-illinois-hospital-corporation-llc/6d62b59a-4ee6-4ea0-8566-e6f3f1a385cc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d